BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2735767
Number of visits today
858
Number of downloads
2006353
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Zhang R, Liu T, Li W, Ma Z, Pei P, Zhang W, Yang K, Tao Y. Tumor microenvironment-responsive BSA nanocarriers for combined chemo/chemodynamic cancer therapy. J Nanobiotechnology 2022;20:223. [PMID: 35549949 DOI: 10.1186/s12951-022-01442-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Gao X, Feng J, Lv K, Zhou Y, Zhang R, Song S, Zhang H, Wang D. Engineering CeO2/CuO heterostructure anchored on upconversion nanoparticles with boosting ROS generation-primed apoptosis-ferroptosis for cancer dynamic therapy. Nano Res 2023. [DOI: 10.1007/s12274-022-5223-4] [Reference Citation Analysis]
2 Mohanty A, Park I. Protein-Caged Nanoparticles: A Promising Nanomedicine Against Cancer. Chonnam Med J 2023;59:1. [DOI: 10.4068/cmj.2023.59.1.1] [Reference Citation Analysis]
3 Zhai B, Sun J, Shi Y, Zhang X, Zou J, Cheng J, Fan Y, Guo D, Tian H. Review targeted drug delivery systems for norcantharidin in cancer therapy. J Nanobiotechnol 2022;20:509. [DOI: 10.1186/s12951-022-01703-3] [Reference Citation Analysis]
4 Zhao Y, Xie Z, Deng Y, Huang A, He Y, Wen B, Liao X, Chang R, Zhang G, Zhu L, Wang Y, Li T, Zhong Y, Zuo J, Zhang H, Chen M, Liu J, Chen X, Liu H. Photothermal nanobomb blocking metabolic adenosine-A2AR potentiates infiltration and activity of T cells for robust antitumor immunotherapy. Chemical Engineering Journal 2022;450:138139. [DOI: 10.1016/j.cej.2022.138139] [Reference Citation Analysis]
5 Nayak A, Warrier NM, Kumar P. Cancer Stem Cells and the Tumor Microenvironment: Targeting the Critical Crosstalk through Nanocarrier Systems. Stem Cell Rev Rep 2022. [PMID: 35876959 DOI: 10.1007/s12015-022-10426-9] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345